AgeX Therapeutics Stock (NYSEAMERICAN:AGE)


$ 0.75
Today's Range
$0.67 - $0.75
52-Week Range
$0.52 - $1.77
Market Cap

About Agex Therapeutics (NYSEAMERICAN:AGE)


AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as the ischemic heart. Its lead drug-based therapeutic candidate in discovery is AGEX-iTR1547, a drug-based formulation to restore regenerative potential in a range of aged tissues afflicted with degenerative diseases. In addition, the company markets human embryonic stem cells; and GeneCards Database Suite, including genomic interpretation algorithms and analysis tools for use by researchers at pharmaceutical and biotechnology companies, and other institutions. AgeX Therapeutics, Inc. has a research collaboration with the University of California, Irvine on neural stem cell research program for Huntington's disease and other neurological disorders; and Sernova Corp. The company was founded in 2017 and is based in Alameda, California.

Show more

AGE Stock Price

Statistics Highlights (NYSEAMERICAN:AGE)

Shares Outstanding 38.51M Beta 1.54
Public Float 18.45M P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 43.47% Ex-Dividend Date
Held by Institutions 17.94% IPO Date Nov 29, 2018

AGE Financial Summary

Dec 21 Dec 20 Dec 19
Revenue $144.00K $1.87M $1.73M
EBITDA $-7.46M $-9.63M $-11.05M
Net Income $-8.68M $-10.98M $-12.15M
Total Assets $3.15M $3.88M $7.44M
Total Cash $584.00K $527.00K $2.35M
Total Debt $6.06M $5.86M $1.96M
Mar 22 Dec 21 Sep 21
Revenue $5.00K $27.00K $24.00K
EBITDA $-2.05M $-1.60M $-1.64M
Net Income $-2.71M $-2.16M $-1.96M
Total Assets $2.72M $3.15M $2.43M
Total Cash $448.00K $584.00K $731.00K
Total Debt $6.66M $6.06M $11.41M

AGE Stock Price History

Agex Therapeutics Annual Stock Price History

Year Open Close Change
2021 $0.60 $0.75 25.00%
2021 $1.58 $0.60 -62.03%
2020 $1.70 $1.58 -7.06%

Agex Therapeutics Daily Stock Price History

Date Open High Low Close Change Volume
Jun 15, 2022 $0.64 $0.74 $0.64 $0.68 3.27% 35.11K
Jun 22, 2022 $0.60 $0.66 $0.60 $0.66 14.67% 9.56K
Jun 24, 2022 $0.60 $0.64 $0.57 $0.57 -21.48% 51.87K


What is today's stock price of Agex Therapeutics (NYSEAMERICAN:AGE)?

  • The current stock price of Agex Therapeutics (NYSEAMERICAN:AGE) is $0.75.
  • Today AGE stock price opened at $0.70 after previous close of $0.69.
  • During the day, Agex Therapeutics stock quote has varied from a low of $0.67 to a high of $0.75.

What is Agex Therapeutics's 52-week change?

  • AGE 52-week high stock quote is $1.77, which is 136.00% above the current share price.
  • The Agex Therapeutics (NYSEAMERICAN:AGE) 52-week low stock price is $0.52, which is 31.20% below the current share price.
  • Agex Therapeutics share price volatility (52-week beta) is 1.54.

Agex Therapeutics (NYSEAMERICAN:AGE) FAQ

How Much is Agex therapeutics Worth?

Agex therapeutics's worth today based on market capitalisation is $28.88M

How much money does Agex therapeutics make?

Last quarter (ended on March 31 ,2022) Agex therapeutics generated a net income of $-2.71M, representing a 22.84% decrease compared to the same quarter a year before (ended on March 31 ,2021).
Last fiscal year (ended on December 31 ,2021) Agex therapeutics generated a net income of $-8.68M, representing a 20.96% decrease compare to the previous fiscal year (ended on December 31 ,2020).
View More Details on Agex therapeutics's “Financials” Section

How much dividend does Agex therapeutics Pay?

The current annualized dividend payout for AGE stock is $0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Agex therapeutics's "Dividend" Section

When is the next earnings date for Agex therapeutics (NYSEAMERICAN:AGE)?

Agex therapeutics is expected to report earnings on August 10 ,2022.
View More Details on Agex therapeutics's 'Earnings' Section

What is Agex therapeutics’s Price to Earning (PE) ratio?

AGE stock also has a Price to Sales (P/S) ratio of 200.58.

What is the Agex therapeutics's ticker?

Agex therapeutics trades on the NYSE American stock market in USA under the ticker symbol "AGE". Agex therapeutics’s stock symbol can also be displayed as "NYSEAMERICAN:AGE".

When did AGE go public?

Agex therapeutics completed its initial public offering (IPO) on November 29 ,2018.

Who are the owners of Agex therapeutics?

Agex therapeutics (NYSEAMERICAN:AGE) is owned by 17.94% institutional shareholders and by 43.47% insiders. The rest is owned by the public.
Explore More Details on Agex therapeutics's “Ownership” Section

Who are the key executives of Agex therapeutics (AGE)?

Agex therapeutics's key executive team includes the following managers:

  • Dr. Michael D. West Ph.D., Founder, Pres, CEO & Director (1953)
  • Ms. Eun-Jae Park CPA, Chief Financial Officer (1972)
  • Dr. Nafees Naseer Malik M.D., Chief Operating Officer (1977)
  • Dr. Ivan Labat, Chief Information Officer (NA)
  • Ms. Judith Segall, Sec. (1953)

What is Agex therapeutics’s Sector & Industry Classification?

Agex therapeutics (NYSEAMERICAN:AGE) is classified under the "Healthcare" sector and under the "Biotechnology" industry.

How many employees work for Agex therapeutics?

Currently the number of employees working for Agex therapeutics is 5.

Where are Agex therapeutics's Headquarters?

Agex therapeutics (NYSEAMERICAN:AGE) is headquartered in CA, United States.

What are Agex therapeutics's Address and Phone Number?

Agex therapeutics’s mailing address is 1101 Marina Village Parkway, Alameda, CA, United States, 94501.
The company’s phone number is 510 671 8370.

What is the official website for Agex therapeutics?

Agex therapeutics’s official website is